BioSpace News Archive

Drug Development

Seattle Children’s Opens Immunotherapy Trial For Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain

CAR T-cell immunotherapy targeting HER2 protein on cancer cells aims to provide children and young adults who have limited treatment options with a second line of defense

June 19, 2018
·
6 min read
BioMidwest

HFMA Awards ‘Peer Reviewed’ Designation to Kaufman Hall’s Axiom Healthcare Suite

Kaufman Hall’s Axiom Healthcare Suite again earned the “Peer Reviewed by HFMA” designation from Healthcare Financial Management Association (HFMA)

June 19, 2018
·
4 min read
Business

FEops Strengthens Management Team

FEops announced the expansion of its management team with the appointments of Christian Vincent as Director of Therapy Development and Nico Uwents as Director of Business Development.

June 19, 2018
·
1 min read
FDA

Bay Labs’ EchoMD AutoEF Software Receives FDA Clearance for Fully Automated AI Echocardiogram Analysis

Innovative AI Algorithms Automate Both Clip Selection and Ejection Fraction Calculation

June 19, 2018
·
3 min read
Pharm Country

United Spinal to Host Arkansas Disability Advocate Cheri Arnold for “Roll on Capitol Hill” in D.C.

Roll to Advocate to Strengthen Department of Veterans Affairs’ Healthcare Services

June 19, 2018
·
3 min read
Transformative Education and Healthcare Technologies Delivering Smart Cities Benefits Beyond Legacy Infrastructure Models

Next-Gen eLearning and eHealth Will Boost Economic Development

June 19, 2018
·
4 min read
Business

Pharmatech Appoints New Chief Financial Officer

Pharmatech Associates announces the expansion of its executive management team

June 19, 2018
·
2 min read
Drug Development

Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone’s Activity Against Human Cytomegalovirus And Malaria

Preclinical Data Further Supports Potential For Treatment of HCMV and Malaria

June 19, 2018
·
5 min read
Policy

Luye Pharma Bolsters Its Global Analgesics Portfolio with China Class 1.1 New Compound LY03012 to Start Phase I Clinical Trials

Luye Pharma Group announced that clinical applications of the company’s new compound candidate have been formally accepted by the China Food and Drug Administration.

June 19, 2018
·
2 min read
Business

Michael A. Smith, MD promoted to director of education at Life Extension

Senior health scientist will expand consumer education about dietary supplements and natural health alternatives.

June 19, 2018
·
2 min read